Separation systems play a vital role in industrial biotechnology processes. These systems produce the desired products from small to large quantities and has wide area of applications. Liquid chromatography, membrane filters, flow cytometer instruments, centrifugation systems, and electrophoresis instruments are the major segments of the market. Each of the systems uses different method to carry out separations in the biotechnology, bio-pharmaceutical, agriculture, energy industries, etc.
The global Separation systems market for Commercial Biotechnology is anticipated to grow at a significant rate during the forecast period due to technological advancements, increasing awareness through conferences and exhibition, rising support and participation of government agencies, investment in R&D, and increase in number of biotechnology firms.
Chromatography systems have gained widespread popularity due to the introduction of novel technologies in chromatographic instruments and consumables. Flow cytometry has emerged as a leading, application-rich technology. Increasing demand and advancement of microarray technology boosts market growth. Laboratory automation has enabled scientists to process samples at low cost, and thus has played a major role in the experiments. Increasing number of conferences in the U.S., Europe, and Asia-Pacific is aiming to spread the new and upcoming innovations in the separation systems market. Growing awareness about chromatography has induced government organizations in the U.S., Europe, and Asia-Pacific to increase their investments, grants, and funds for the development of chromatography. Some of the market restrains includes high cost of systems and technologies, lack of innovation in electrophoresis equipment technology, and patent rights over MACS technique.
The global separation systems for commercial biotechnology market has been estimated based on product type, end-user, and geography. Based on product type, the global market has been segmented into liquid chromatography, membrane filters, electrophoresis instruments, flow-cytometer instruments, centrifugation systems, DNA microarray instruments, protein microarray instruments, MACS & FACS systems, and others. The liquid chromatography systems segment held the largest share of the market in 2014. The segment is likely to continue to dominate the market during the forecast period. Based on end-user, the separation systems market has been segmented into life sciences research and diagnostics, pharmaceuticals, food & cosmetics, energy, and agriculture.
Request free Sample pages of premium Research Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2104
The life sciences research and diagnostics end-user segment held the largest share of the market in 2014. The segment is anticipated to continue to dominate the market during the forecast period. It is also expected to record the fastest growth from 2015 to 2023. Rising number of genomic and proteomic researches in the life sciences research segment has increased demand for separation systems.
Geographically, the separation systems market has been categorized into four regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). North America held the largest share of the ultrasound devices market in 2014, followed by Europe. Asia Pacific was identified as the third largest market for ultrasound devices in 2014. The market in the region is expected to expand at a low CAGR during the forecast period. The reason for low market revenue and growth in North America is due to the high usage of other imaging technologies.
Danaher Corporation, Thermo Fisher Scientific, Inc., Waters Corporation, Becton, Dickinson and Company, GE Healthcare, and Merck KGaA are the major players operating in the global separation systems for commercial biotechnology market. Danaher Corporation is the leading player in the market.